Bridge therapy to liver transplantation in fulminant hepatic failure

Research output: Contribution to journalArticle

Abstract

The management of patients with fulminant hepatic failure is a major clinical endeavor. Early intensive care at an institution able to perform liver transplantation is essential. It is recognized that therapy focused solely on attempts at preventing/reversing increased intracranial pressure, and the treatment of other failing organs as they occur falls well short of ideal. This review covers the non-biological and biological techniques utilized in efforts to support liver function. The goal is to foster recovery, or to buy enough time for successful liver transplantation. Prospective, controlled trials are beginning to acknowledge subgroups of fulminant hepatic failure and properly randomize therapy. Our understanding of the essential elements of liver support is improving, but no single device has yet proved indispensable.

Original languageEnglish (US)
Pages (from-to)713-719
Number of pages7
JournalCurrent Opinion in Anaesthesiology
Volume14
Issue number6
DOIs
StatePublished - 2001

Fingerprint

Acute Liver Failure
Liver Transplantation
Liver
Intracranial Pressure
Critical Care
Therapeutics
Equipment and Supplies

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Bridge therapy to liver transplantation in fulminant hepatic failure. / Merritt, William T.

In: Current Opinion in Anaesthesiology, Vol. 14, No. 6, 2001, p. 713-719.

Research output: Contribution to journalArticle

@article{89f7cefc52554ee19479b255fd258982,
title = "Bridge therapy to liver transplantation in fulminant hepatic failure",
abstract = "The management of patients with fulminant hepatic failure is a major clinical endeavor. Early intensive care at an institution able to perform liver transplantation is essential. It is recognized that therapy focused solely on attempts at preventing/reversing increased intracranial pressure, and the treatment of other failing organs as they occur falls well short of ideal. This review covers the non-biological and biological techniques utilized in efforts to support liver function. The goal is to foster recovery, or to buy enough time for successful liver transplantation. Prospective, controlled trials are beginning to acknowledge subgroups of fulminant hepatic failure and properly randomize therapy. Our understanding of the essential elements of liver support is improving, but no single device has yet proved indispensable.",
author = "Merritt, {William T}",
year = "2001",
doi = "10.1097/00001503-200112000-00019",
language = "English (US)",
volume = "14",
pages = "713--719",
journal = "Current Opinion in Anaesthesiology",
issn = "0952-7907",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Bridge therapy to liver transplantation in fulminant hepatic failure

AU - Merritt, William T

PY - 2001

Y1 - 2001

N2 - The management of patients with fulminant hepatic failure is a major clinical endeavor. Early intensive care at an institution able to perform liver transplantation is essential. It is recognized that therapy focused solely on attempts at preventing/reversing increased intracranial pressure, and the treatment of other failing organs as they occur falls well short of ideal. This review covers the non-biological and biological techniques utilized in efforts to support liver function. The goal is to foster recovery, or to buy enough time for successful liver transplantation. Prospective, controlled trials are beginning to acknowledge subgroups of fulminant hepatic failure and properly randomize therapy. Our understanding of the essential elements of liver support is improving, but no single device has yet proved indispensable.

AB - The management of patients with fulminant hepatic failure is a major clinical endeavor. Early intensive care at an institution able to perform liver transplantation is essential. It is recognized that therapy focused solely on attempts at preventing/reversing increased intracranial pressure, and the treatment of other failing organs as they occur falls well short of ideal. This review covers the non-biological and biological techniques utilized in efforts to support liver function. The goal is to foster recovery, or to buy enough time for successful liver transplantation. Prospective, controlled trials are beginning to acknowledge subgroups of fulminant hepatic failure and properly randomize therapy. Our understanding of the essential elements of liver support is improving, but no single device has yet proved indispensable.

UR - http://www.scopus.com/inward/record.url?scp=0035204376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035204376&partnerID=8YFLogxK

U2 - 10.1097/00001503-200112000-00019

DO - 10.1097/00001503-200112000-00019

M3 - Article

VL - 14

SP - 713

EP - 719

JO - Current Opinion in Anaesthesiology

JF - Current Opinion in Anaesthesiology

SN - 0952-7907

IS - 6

ER -